Discuss how Lab in the Loop is revolutionizing drug discovery by integrating AI with experimental workflows, enhancing speed and accuracy in data collection and analysis.
Generoso Iannicello
Generoso Ianniciello is a strategic leader in life sciences with expertise in multi-omics, diagnostics, biopharma, and platform services. As Chief Business Officer at Anima Biotech, he leads the global strategy for the Biology GPU - a new category in drug discovery infrastructure that connects how AI thinks with how biology works, tackling one of the biggest challenges in the field.
Previously, as CBO at Dante Genomics, he scaled the start-up into a global enterprise with over 200 employees and $100 million in annual revenue. He launched the Dante MyGenome Platform for longevity, personalized medicine, and rare disease diagnostics, and built key partnerships with hospitals, biopharma, and research institutions worldwide.
